Form 4: CRISPR Therapeutics CFO Receives Stock Options and Restricted Stock Units
SEC Form 4 Filing
Raju Prasad, CFO of CRISPR Therapeutics, was granted stock options for 18,333 common shares and 15,000 restricted stock units on October 16, 2024.
Summary
- On October 16, 2024, Raju Prasad, the Chief Financial Officer of CRISPR Therapeutics, received stock options and restricted stock units.
- The stock options grant covers 18,333 common shares with an exercise price of $49.
- These options vest in 48 equal monthly installments starting November 16, 2024.
- Additionally, Prasad received 15,000 restricted stock units, each representing a contingent right to receive one share of CRSP common stock.
- These restricted stock units will vest on October 16, 2027.
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, indicating stability and alignment of interests. It's a neutral-to-positive event.
Positives
- The grant of stock options and restricted stock units aligns the CFO's interests with those of the shareholders.
- The vesting schedules incentivize long-term performance and retention.
Industry Context
Stock options and restricted stock units are common forms of executive compensation in the biotechnology industry, used to attract and retain talent and align their interests with those of shareholders.
Comparison to Industry Standards
- Executive compensation packages in the biotech industry typically include a mix of salary, bonus, stock options, and restricted stock units.
- Companies like Vertex Pharmaceuticals and BioMarin Pharmaceutical also utilize similar equity-based compensation plans for their executives.
- The vesting schedules are fairly standard, with options vesting over 4 years and restricted stock units vesting over 3 years.
Stakeholder Impact
- Shareholders may view the equity grants as a positive sign, aligning management's interests with long-term value creation.
- Employees may see this as a positive sign of company health and commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 10/16/2024 | Date of transaction: Grant of stock options and restricted stock units. |
| 11/16/2024 | First vesting date for the stock options. |
| 10/16/2027 | Vesting date for the restricted stock units. |
| 10/18/2024 | Date of filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.